vs
MAXIMUS, INC.(MMS)とRB GLOBAL INC.(RBA)の財務データ比較。上の社名をクリックして会社を切り替えられます
MAXIMUS, INC.の直近四半期売上が大きい($1.3B vs $1.2B、RB GLOBAL INC.の約1.1倍)。RB GLOBAL INC.の純利益率が高く(9.1% vs 7.0%、差は2.1%)。RB GLOBAL INC.の前年同期比売上増加率が高い(5.4% vs -4.1%)。RB GLOBAL INC.の直近四半期フリーキャッシュフローが多い($186.5M vs $-250.7M)。過去8四半期でRB GLOBAL INC.の売上複合成長率が高い(6.3% vs -0.1%)
MAXIMUS社は米国の政府向けサービス企業で、米国、カナダ、英国などで事業を展開している。メディケイド、メディケア、医療改革、就労支援、学生ローン管理など各種政府プログラムに管理業務や関連サービスを提供する。本社はバージニア州タイソンズに所在し、従業員数3万9600人、2024会計年度の売上高は53億米ドルである。
リッチーブラザーズオークショニア(証券コードRBA)はカナダに登記されている上場企業で、本社は米国イリノイ州ウェストチェスターに所在し、普通株式はトロント証券取引所とニューヨーク証券取引所の両方で取引されています。
MMS vs RBA — 直接比較
損益計算書 — Q1 FY2026 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $1.3B | $1.2B |
| 純利益 | $93.9M | $109.7M |
| 粗利率 | 23.7% | — |
| 営業利益率 | 10.9% | 14.7% |
| 純利益率 | 7.0% | 9.1% |
| 売上前年比 | -4.1% | 5.4% |
| 純利益前年比 | 128.0% | -7.4% |
| EPS(希薄化後) | $1.70 | $0.53 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.3B | $1.1B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.3B | $981.8M | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | $1.3B | $1.1B |
| Q4 25 | $93.9M | $109.7M | ||
| Q3 25 | $75.3M | $95.5M | ||
| Q2 25 | $106.0M | $109.8M | ||
| Q1 25 | $96.6M | $113.4M | ||
| Q4 24 | $41.2M | $118.5M | ||
| Q3 24 | $72.5M | $76.1M | ||
| Q2 24 | $89.8M | $111.1M | ||
| Q1 24 | $80.5M | $107.4M |
| Q4 25 | 23.7% | — | ||
| Q3 25 | 25.3% | — | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 24.9% | — | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 22.9% | — | ||
| Q2 24 | 25.3% | — | ||
| Q1 24 | 23.6% | — |
| Q4 25 | 10.9% | 14.7% | ||
| Q3 25 | 9.3% | 14.5% | ||
| Q2 25 | 12.3% | 15.9% | ||
| Q1 25 | 11.2% | 17.1% | ||
| Q4 24 | 6.2% | 18.1% | ||
| Q3 24 | 8.5% | 15.6% | ||
| Q2 24 | 10.8% | 18.4% | ||
| Q1 24 | 9.5% | 18.7% |
| Q4 25 | 7.0% | 9.1% | ||
| Q3 25 | 5.7% | 8.7% | ||
| Q2 25 | 7.9% | 9.3% | ||
| Q1 25 | 7.1% | 10.2% | ||
| Q4 24 | 2.9% | 10.4% | ||
| Q3 24 | 5.5% | 7.8% | ||
| Q2 24 | 6.8% | 10.1% | ||
| Q1 24 | 6.0% | 10.1% |
| Q4 25 | $1.70 | $0.53 | ||
| Q3 25 | $1.27 | $0.43 | ||
| Q2 25 | $1.86 | $0.53 | ||
| Q1 25 | $1.69 | $0.55 | ||
| Q4 24 | $0.69 | $0.58 | ||
| Q3 24 | $1.18 | $0.36 | ||
| Q2 24 | $1.46 | $0.54 | ||
| Q1 24 | $1.31 | $0.53 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $137.6M | $531.5M |
| 総負債低いほど良い | — | $2.3B |
| 株主資本純資産 | $1.7B | $5.6B |
| 総資産 | $4.2B | $12.1B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.42× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $137.6M | $531.5M | ||
| Q3 25 | $222.4M | $674.7M | ||
| Q2 25 | $59.8M | $710.2M | ||
| Q1 25 | $108.1M | $578.1M | ||
| Q4 24 | $72.7M | $533.9M | ||
| Q3 24 | $183.1M | $650.7M | ||
| Q2 24 | $102.8M | $599.5M | ||
| Q1 24 | $77.4M | $462.8M |
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | — | $2.9B |
| Q4 25 | $1.7B | $5.6B | ||
| Q3 25 | $1.7B | $5.5B | ||
| Q2 25 | $1.8B | $5.5B | ||
| Q1 25 | $1.7B | $5.3B | ||
| Q4 24 | $1.6B | $5.2B | ||
| Q3 24 | $1.8B | $5.2B | ||
| Q2 24 | $1.8B | $5.2B | ||
| Q1 24 | $1.8B | $5.1B |
| Q4 25 | $4.2B | $12.1B | ||
| Q3 25 | $4.1B | $12.2B | ||
| Q2 25 | $4.5B | $12.2B | ||
| Q1 25 | $4.2B | $11.9B | ||
| Q4 24 | $4.1B | $11.8B | ||
| Q3 24 | $4.1B | $11.9B | ||
| Q2 24 | $4.0B | $12.1B | ||
| Q1 24 | $4.0B | $12.0B |
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.47× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.52× | ||
| Q2 24 | — | 0.55× | ||
| Q1 24 | — | 0.58× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-244.4M | $255.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $-250.7M | $186.5M |
| FCFマージンFCF / 売上 | -18.6% | 15.5% |
| 設備投資強度設備投資 / 売上 | 0.5% | 5.7% |
| キャッシュ転換率営業CF / 純利益 | -2.60× | 2.33× |
| 直近12ヶ月FCF直近4四半期 | $218.5M | $719.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-244.4M | $255.2M | ||
| Q3 25 | $649.4M | $239.7M | ||
| Q2 25 | $-182.7M | $326.5M | ||
| Q1 25 | $42.7M | $156.8M | ||
| Q4 24 | $-80.0M | $184.5M | ||
| Q3 24 | $163.8M | $285.4M | ||
| Q2 24 | $199.3M | $337.3M | ||
| Q1 24 | $130.5M | $124.8M |
| Q4 25 | $-250.7M | $186.5M | ||
| Q3 25 | $641.8M | $188.5M | ||
| Q2 25 | $-198.2M | $241.7M | ||
| Q1 25 | $25.5M | $102.5M | ||
| Q4 24 | $-103.0M | $127.9M | ||
| Q3 24 | $131.9M | $248.5M | ||
| Q2 24 | $164.6M | $308.6M | ||
| Q1 24 | $105.2M | $79.6M |
| Q4 25 | -18.6% | 15.5% | ||
| Q3 25 | 48.7% | 17.3% | ||
| Q2 25 | -14.7% | 20.4% | ||
| Q1 25 | 1.9% | 9.2% | ||
| Q4 24 | -7.3% | 11.2% | ||
| Q3 24 | 10.0% | 25.3% | ||
| Q2 24 | 12.5% | 28.2% | ||
| Q1 24 | 7.8% | 7.5% |
| Q4 25 | 0.5% | 5.7% | ||
| Q3 25 | 0.6% | 4.7% | ||
| Q2 25 | 1.1% | 7.2% | ||
| Q1 25 | 1.3% | 4.9% | ||
| Q4 24 | 1.6% | 5.0% | ||
| Q3 24 | 2.4% | 3.8% | ||
| Q2 24 | 2.6% | 2.6% | ||
| Q1 24 | 1.9% | 4.2% |
| Q4 25 | -2.60× | 2.33× | ||
| Q3 25 | 8.63× | 2.51× | ||
| Q2 25 | -1.72× | 2.97× | ||
| Q1 25 | 0.44× | 1.38× | ||
| Q4 24 | -1.94× | 1.56× | ||
| Q3 24 | 2.26× | 3.75× | ||
| Q2 24 | 2.22× | 3.04× | ||
| Q1 24 | 1.62× | 1.16× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MMS
| Clinical Services | $523.7M | 39% |
| Cost Plus Contracts | $386.4M | 29% |
| Outside The United States | $143.2M | 11% |
| International Government Agencies | $141.0M | 10% |
| Technology Solutions | $74.8M | 6% |
| Employment And Other | $70.2M | 5% |
| Other Including Local Municipalities And Commercial Customers | $17.6M | 1% |
RBA
| Buyer Revenue | $577.2M | 48% |
| Seller Revenue | $255.2M | 21% |
| CA | $199.0M | 17% |
| Other | $124.7M | 10% |
| AU | $47.3M | 4% |